Quantifying Systemic Immunosuppression to Personalize Cancer Therapy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Quantifying Systemic Immunosuppression to Personalize Cancer Therapy — Stella

View on ClinicalTrials.gov

Recruiting

Back to Melanoma trials

Trial locations(1 site)

Italy

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

Key details

Sponsor

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Enrollment target

~1,000 participants

Started

March 2022

Primary completion

December 2026

Age range

18 Years – 90 Years

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.